Story perspectives

Upcoming Earnings: Vertex, Upstart, and EA Predictions

5/2/2025

50 7

Summary

Earnings Reports Insight

Vertex Pharmaceuticals (VRTX) will report earnings on May 5, 2025, with an expected EPS of $4.29 and $2.86 billion in sales, historically showing a 58% chance of positive one-day returns.
Upstart (UPST) is set to announce earnings on May 6, 2025, projecting an EPS of $0.17 and revenue of $201 million, with a 53% likelihood of positive returns and a median gain of 34.6%.
Electronic Arts (EA) will also report on May 6, 2025, anticipating an EPS of $0.91 and $1.55 billion in revenue, with a balanced 50% chance of positive returns.

Summary

Microsoft Exceeds Earnings

Microsoft (MSFT) exceeded Q3 2025 earnings estimates, reporting $3.46 per share and $70.1 billion in revenue, a 13% increase year-over-year.
Azure cloud services fueled growth, achieving a 33% revenue rise, leading to a 9.2% stock increase post-report.
Amazon (AMZN) stock gained 3% ahead of its earnings report, driven by optimism from Microsoft's cloud success.
Analysts expect Amazon's Q1 adjusted earnings at $1.37 per share, with sales projected to rise 8% to $155.15 billion, despite tariff concerns.

History

Historical Context

Vertex Pharmaceuticals' upcoming earnings report echoes the historical trend of biotech firms driving market optimism. Since the 1970s, biotech innovations have reshaped healthcare, often resulting in stock surges post-earnings. This pattern highlights investor reliance on biotech for growth, reminiscent of tech booms in the late 1990s.

1 of 3

Earnings Reports Insight

Vertex Pharmaceuticals (VRTX) will report earnings on May 5, 2025, with an expected EPS of $4.29 and $2.86 billion in sales, historically showing a 58% chance of positive one-day returns.
Upstart (UPST) is set to announce earnings on May 6, 2025, projecting an EPS of $0.17 and revenue of $201 million, with a 53% likelihood of positive returns and a median gain of 34.6%.
Electronic Arts (EA) will also report on May 6, 2025, anticipating an EPS of $0.91 and $1.55 billion in revenue, with a balanced 50% chance of positive returns.

1 / 3